23andMe founder Anne Wojcicki will regain management of embattled DNA firm in spite of everything

In a shock twist, 23andMe founder and former CEO Anne Wojcicki is ready to regain management of the DNA firm’s property, according to a press release from 23andMe. In Might, an organization known as Regeneron bought 23andMe for $256 million in a chapter public sale, however Wojcicki’s nonprofit, TTAM Analysis Institute, was capable of reopen bidding with an “unsolicited provide” of $305 million, The Wall Street Journal reports.

A chapter choose agreed to reopen bidding on 23andMe underneath the situation that Regeneron prime Wojcicki’s proposed worth by at the very least $10 million, in response to WSJ. Regeneron declined, leaving 23andMe in TTAM’s management assuming the choose approves the deal. A listening to to contemplate the brand new deal is ready for June 17, 2025.

Regeneron had beforehand deliberate to maintain on all the firm’s workers and proceed providing client DNA testing kits. Apart from answering prospects’ questions on their ancestry, 23andMe’s genetic knowledge is efficacious as a method to establish attainable well being dangers, and within the case of Regeneron, as a device for figuring out drug targets.

It isn’t fully clear what Wojcicki intends to do subsequent, however 23andMe’s announcement features a checklist of buyer knowledge and privateness protections TTAM Analysis Institute has agreed to, together with persevering with to permit prospects to delete their knowledge and opt-out of analysis, establishing a Shopper Privateness Advocacy Board and promising to “not promote or switch genetic knowledge” within the occasion of one other chapter — except the customer agrees to the identical privateness protections.

Sustaining management of the corporate’s property has been Wojcicki’s plan since 23andMe declared bankruptcy in March 2025. She initially resigned as the corporate’s CEO to make a bid on the corporate.

“I’m thrilled that TTAM Analysis Institute will be capable of proceed the mission of 23andMe to assist folks entry, perceive and profit from the human genome,” Wojcicki says. “We consider it’s essential that people are empowered to have alternative and transparency with respect to their genetic knowledge and have the chance to proceed to find out about their ancestry and well being dangers as they want.”

23andMe had a turbulent few years previous to declaring chapter, struggling a knowledge breach in 2023 that impacted millions of customers and mass layoffs in 2024 that affected 40 percent of the corporate’s employees.

If you happen to purchase one thing by way of a hyperlink on this article, we could earn fee.